Seiji Sakata

RET, ROS1 and ALK fusions in lung cancer

Kengo Takeuchi, Manabu Soda, Yuki Togashi et al. · Nature Medicine · 2012 · 1.3K citations

Oncology, Medicine, Cancer Genetics +4

Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers

Keisuke Kataoka, Yuichi Shiraishi, Yohei Takeda et al. · Nature · 2016 · 627 citations

Aberrant Pd-l1 Expression, Cancer Cell Biology, Pathology +5

Somatic RHOA mutation in angioimmunoblastic T cell lymphoma

Mamiko Sakata‐Yanagimoto, Terukazu Enami, Kenichi Yoshida et al. · Nature Genetics · 2014 · 625 citations

Lymphoid Neoplasia, Somatic Variant, Immunology +4

KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only

Yuki Togashi, Manabu Soda, Seiji Sakata et al. · PLoS ONE · 2012 · 261 citations · Full text

Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer

Bo Gong, Kazuma Kiyotani, Seiji Sakata et al. · The Journal of Experimental Medicine · 2019 · 237 citations · Full text